Max Wygod

Forian Inc. (NASDAQ: FORA) announced the sale of its cannabis software subsidiary, Bio-Tech Medical Software, Inc. (d/b/a BioTrack), to Alleaves, Inc., effective February 10, 2023, for a total purchase price of $30 million in cash, comprised of $20 million paid at closing and $10 million paid in...

Forian Inc. (NASDAQ: FORA) released financial results for the quarter ended September 30, 2022, revealing revenue of $7.2 million, a 45% increase compared to $5 million in the Q3 2021 and 10% sequentially over the second quarter of 2022. Q3 2022 Financial Highlights Net loss for the quarter was $...

Forian Inc. (NASDAQ: FORA) released results for the quarter ended June 30, 2022. Q2 2022 Financial Highlights Revenue for the quarter was $6.5 million, an increase of 44% versus the prior year and 2% sequentially over the first quarter of 2022. Net loss for the quarter was $5.4 million, or $0...

Forian Inc. (NASDAQ: FORA), a provider of technology, analytics and data science driven solutions for the healthcare and cannabis industries, announced financial results for the quarter and year ended December 31, 2021. “We have achieved many milestones in the last year,” said Max...

Forian Inc. (NASDAQ: FORA), a provider of technology, analytics and science-driven data solutions for the healthcare and cannabis industries, announced its financial results for the fiscal quarter ended September 30, 2021. Third Quarter 2021 Financial Results Revenue for the quarter was...

Village Farms’ Colorado Subsidiary Taps Alejandro de Gortari As CFO Village Farms International, Inc. (NASDAQ: VFF) (TSX: VFF) announced Monday that its Colorado subsidiary Balanced Health Botanicals has appointed consumer products and finance veteran, Alejandro...

Forian Inc. (NASDAQ: FORA) announced on Wednesday a $24 million valued private placement of 3.5% convertible notes. The company, which provides analytics services and software solutions to healthcare and cannabis industries, also revealed it has appointed Michael Vesey as the new Chief...